Apple Inc. is getting ready to release new Mac laptops and desktop computers. These new devices will come with a new design, faster processors and better connectivity to external devices. This should allow the company to accelerate the efforts to fully replace Intel Corp chips with a new inhouse M1 chip already found in the iPhone and iPad. Those chips are known for consuming less power and allow the laptops to run the same apps as the mobile devices.
.png?width=4920&name=Graph%20Template%20(9).png)
Apple said on Tuesday that the new 24-inch iMac will be available in stores on May 21, currently the stock price remains unchanged, but we could see some movements in the short term.
Apple is the fourth leading seller with 15% of the U.S. market, an increase from 12% in the quarter from the previous year, and 8% globally. The Mac line of products has been a big contributor to the company’s revenue, generating $9.1 billion in the first quarter, 10% of total sales. When people see the newest and latest Mac products, will they wait in line to be the first to grab them?
Apple plans to replace the last remaining Intel part with an in-house version as early as 2022. Apple’s current M1 Macs still use an Intel component known as a USB Retimer, which helps power the USB-C and Thunderbolt ports on its computers. This would mean Apple no longer needs to rely on Intel for any parts. How will that affect both Apple and Intel?
We love to hear new ideas from traders and want to know what you think!
If you like this topic and want to suggest future topics that you find helpful, let us know by clicking the ‘submit your feedback’ button below.
Trading foreign exchange on margin carries a high level of risk, and may not be suitable for all investors. Before deciding to trade foreign exchange you should carefully consider your investment objectives, level of experience, and risk appetite.
Nothing contained in this website should be construed as investment advice. Any reference to an investment's past or potential performance is not, and should not be construed as, a recommendation or as a guarantee of any specific outcome or profit.
